At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Restylane Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Multi-center, Subject and Evaluator-blinded Study Comparing Pain and Safety Profile Associated With Correction of Moderate to Severe Nasolabial Folds Using Restylane With and Without Addition of 0.3% Lidocaine Hydrochloride
In Brief
A clinical study evaluating Restylane Lidocaine and Restylane for Nasolabial Fold. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the pain and safety associated with injections of Restylane Lidocaine compared to Restylane using a visual analogue scale.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Fold
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartFeb 2017
Primary CompletionApr 2017
Study CompletionMay 2017
TodayJul 2026
First PostedSep 29, 2016
Enrollment StartFeb 8, 2017
Primary CompletionApr 27, 2017
Study CompletionMay 11, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.8 years ago
Interventions
Restylane Lidocainedevice
Intradermal injection
Restylanedevice
Intradermal injection